Development of a competitive enzyme-linked immunosorbent assay for therapeutic drug monitoring of afatinib

This publication has 23 references indexed in Scilit:

• Fast quantitative analysis of four tyrosine kinase inhibitors in different human plasma samples using three‐way calibration‐ assisted liquid chromatography with diode array detection
  Journal of Separation Science, 2015
• Pooled safety analysis of EGFR-TKI treatment for EGFR mutation-positive non-small cell lung cancer
  Lung Cancer, 2015
• Practical Guidelines for Therapeutic Drug Monitoring of Anticancer Tyrosine Kinase Inhibitors: Focus on the Pharmacokinetic Targets
  Clinical Pharmacokinetics, 2014
• A Limited Sampling Strategy for Estimation of the Area Under the Plasma Concentration–Time Curve of Gefitinib
  Therapeutic Drug Monitoring, 2014
• Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
  Journal of Clinical Oncology, 2013
• Afatinib: First Global Approval
  Drugs, 2013
• Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial
  The Lancet Oncology, 2012
• Recognition of imidazole and histamine derivatives by monoclonal antibodies
  Molecular Immunology, 1990
• A direct enzyme immunoassay of 6.BETA.-hydroxycortisol in human urine.
  Chemical and Pharmaceutical Bulletin, 1981
• Determination of free amino groups in proteins by trinitrobenzenesulfonic acid
  Analytical Biochemistry, 1966